566 related articles for article (PubMed ID: 23476052)
1. Idiosyncratic adverse drug reactions: current concepts.
Uetrecht J; Naisbitt DJ
Pharmacol Rev; 2013 Apr; 65(2):779-808. PubMed ID: 23476052
[TBL] [Abstract][Full Text] [Related]
2. How Reactive Metabolites Induce an Immune Response That Sometimes Leads to an Idiosyncratic Drug Reaction.
Cho T; Uetrecht J
Chem Res Toxicol; 2017 Jan; 30(1):295-314. PubMed ID: 27775332
[TBL] [Abstract][Full Text] [Related]
3. Idiosyncratic Drug Reactions: A 35-Year
Uetrecht J
Chem Res Toxicol; 2022 Oct; 35(10):1649-1654. PubMed ID: 35687011
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the immune system in idiosyncratic drug reactions.
Zhang X; Liu F; Chen X; Zhu X; Uetrecht J
Drug Metab Pharmacokinet; 2011; 26(1):47-59. PubMed ID: 21084762
[TBL] [Abstract][Full Text] [Related]
5. The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions.
Sernoskie SC; Jee A; Uetrecht JP
Pharmacol Rev; 2021 Jul; 73(3):861-896. PubMed ID: 34016669
[TBL] [Abstract][Full Text] [Related]
6. Idiosyncratic drug reactions: past, present, and future.
Uetrecht J
Chem Res Toxicol; 2008 Jan; 21(1):84-92. PubMed ID: 18052104
[TBL] [Abstract][Full Text] [Related]
7. Immune-mediated adverse drug reactions.
Uetrecht J
Chem Res Toxicol; 2009 Jan; 22(1):24-34. PubMed ID: 19149477
[TBL] [Abstract][Full Text] [Related]
8. Animal models of idiosyncratic drug reactions.
Ng W; Lobach AR; Zhu X; Chen X; Liu F; Metushi IG; Sharma A; Li J; Cai P; Ip J; Novalen M; Popovic M; Zhang X; Tanino T; Nakagawa T; Li Y; Uetrecht J
Adv Pharmacol; 2012; 63():81-135. PubMed ID: 22776640
[TBL] [Abstract][Full Text] [Related]
9. Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis.
Johnston A; Uetrecht J
Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):243-57. PubMed ID: 25424130
[TBL] [Abstract][Full Text] [Related]
10. Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune Receptors.
Pichler WJ; Adam J; Watkins S; Wuillemin N; Yun J; Yerly D
Int Arch Allergy Immunol; 2015; 168(1):13-24. PubMed ID: 26524432
[TBL] [Abstract][Full Text] [Related]
11. Activation of inflammasomes by agents causing idiosyncratic skin reactions: a possible biomarker.
Weston JK; Uetrecht J
Chem Res Toxicol; 2014 Jun; 27(6):949-51. PubMed ID: 24877608
[TBL] [Abstract][Full Text] [Related]
12. Immune mechanisms of idiosyncratic drug-induced liver injury.
Mak A; Uetrecht J
J Clin Transl Res; 2017 Feb; 3(1):145-156. PubMed ID: 30873473
[TBL] [Abstract][Full Text] [Related]
13. The danger hypothesis applied to idiosyncratic drug reactions.
Li J; Uetrecht JP
Handb Exp Pharmacol; 2010; (196):493-509. PubMed ID: 20020274
[TBL] [Abstract][Full Text] [Related]
14. A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity.
Cardone M; Garcia K; Tilahun ME; Boyd LF; Gebreyohannes S; Yano M; Roderiquez G; Akue AD; Juengst L; Mattson E; Ananthula S; Natarajan K; Puig M; Margulies DH; Norcross MA
J Clin Invest; 2018 Jul; 128(7):2819-2832. PubMed ID: 29782330
[TBL] [Abstract][Full Text] [Related]
15. Investigations toward enhanced understanding of hepatic idiosyncratic drug reactions.
Liguori MJ; Waring JF
Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):835-46. PubMed ID: 17125404
[TBL] [Abstract][Full Text] [Related]
16. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.
Ostrov DA; Grant BJ; Pompeu YA; Sidney J; Harndahl M; Southwood S; Oseroff C; Lu S; Jakoncic J; de Oliveira CA; Yang L; Mei H; Shi L; Shabanowitz J; English AM; Wriston A; Lucas A; Phillips E; Mallal S; Grey HM; Sette A; Hunt DF; Buus S; Peters B
Proc Natl Acad Sci U S A; 2012 Jun; 109(25):9959-64. PubMed ID: 22645359
[TBL] [Abstract][Full Text] [Related]
17. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.
Klaewsongkram J; Sukasem C; Thantiworasit P; Suthumchai N; Rerknimitr P; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C;
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):219-227.e4. PubMed ID: 29800753
[TBL] [Abstract][Full Text] [Related]
18. Idiosyncratic drug reactions: current understanding.
Uetrecht J
Annu Rev Pharmacol Toxicol; 2007; 47():513-39. PubMed ID: 16879083
[TBL] [Abstract][Full Text] [Related]
19. NEW STRATEGIES TO PREDICT AND PREVENT SERIOUS IMMUNOLOGICALLY MEDIATED ADVERSE DRUG REACTIONS.
Phillips EJ
Trans Am Clin Climatol Assoc; 2018; 129():74-87. PubMed ID: 30166701
[TBL] [Abstract][Full Text] [Related]
20. HLADR: a database system for enhancing the discovery of biomarkers for predicting human leukocyte antigen-mediated idiosyncratic adverse drug reactions.
Du T; Yang L; Luo H; Zhou P; Mei H; Xuan J; Xing Q; Ning B; Mendrick DL; Shi L
Biomark Med; 2015; 9(11):1079-93. PubMed ID: 26501190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
